Moler-Zapata S, Hutchings A, Grieve R, Hinchliffe R, Smart N, Moonesinghe S
Med Decis Making. 2024; 44(8):944-960.
PMID: 39440442
PMC: 11542320.
DOI: 10.1177/0272989X241289336.
Liu Z, Sun Y, Huang X
Bioinformatics. 2024; 40(10).
PMID: 39374538
PMC: 11483108.
DOI: 10.1093/bioinformatics/btae592.
Selby J, Maas C, Fireman B, Kent D
medRxiv. 2024; .
PMID: 38766150
PMC: 11100853.
DOI: 10.1101/2024.05.06.24306774.
Miladinia M, Jahangiri M, White S, Karimpourian H, Inno A, Chan S
Trials. 2024; 25(1):230.
PMID: 38570861
PMC: 10988831.
DOI: 10.1186/s13063-024-08078-w.
Seo J, Kang G, Kim C, Jung J, Kim J, Kang H
Arch Rehabil Res Clin Transl. 2024; 5(4):100274.
PMID: 38163027
PMC: 10757156.
DOI: 10.1016/j.arrct.2023.100274.
AN OMNIBUS TEST FOR DETECTION OF SUBGROUP TREATMENT EFFECTS VIA DATA PARTITIONING.
Sun Y, He X, Hu J
Ann Appl Stat. 2023; 16(4):2266-2278.
PMID: 37521002
PMC: 10381789.
DOI: 10.1214/21-AOAS1589.
A wide range of missing imputation approaches in longitudinal data: a simulation study and real data analysis.
Jahangiri M, Kazemnejad A, Goldfeld K, Daneshpour M, Mostafaei S, Khalili D
BMC Med Res Methodol. 2023; 23(1):161.
PMID: 37415114
PMC: 10327316.
DOI: 10.1186/s12874-023-01968-8.
A reference-free R-learner for treatment recommendation.
Zhou J, Zhang Y, Tu W
Stat Methods Med Res. 2022; 32(2):404-424.
PMID: 36540907
PMC: 11376343.
DOI: 10.1177/09622802221144326.
A nonparametric method for classification trees using grouped covariates.
Lin F, Shih Y, Yu Y
Biom J. 2022; 65(2):e2100107.
PMID: 36161314
PMC: 9925394.
DOI: 10.1002/bimj.202100107.
Ultrasound-based radiomics technology in fetal lung texture analysis prediction of neonatal respiratory morbidity.
Du Y, Jiao J, Ji C, Li M, Guo Y, Wang Y
Sci Rep. 2022; 12(1):12747.
PMID: 35882938
PMC: 9325724.
DOI: 10.1038/s41598-022-17129-8.
A Computational Framework for Identifying Age Risks in Drug-Adverse Event Pairs.
Zhao Z, Liu R, Wang L, Li L, Song C, Zhang P
AMIA Jt Summits Transl Sci Proc. 2022; 2022:524-533.
PMID: 35854736
PMC: 9285161.
Predictive modeling of COPD exacerbation rates using baseline risk factors.
Singh D, Hurst J, Martinez F, Rabe K, Bafadhel M, Jenkins M
Ther Adv Respir Dis. 2022; 16:17534666221107314.
PMID: 35815359
PMC: 9340368.
DOI: 10.1177/17534666221107314.
CAPITAL: Optimal subgroup identification via constrained policy tree search.
Cai H, Lu W, Marceau West R, Mehrotra D, Huang L
Stat Med. 2022; 41(21):4227-4244.
PMID: 35799329
PMC: 9544117.
DOI: 10.1002/sim.9507.
A Machine-Learning Approach for Estimating Subgroup- and Individual-Level Treatment Effects: An Illustration Using the 65 Trial.
Sadique Z, Grieve R, Diaz-Ordaz K, Mouncey P, Lamontagne F, ONeill S
Med Decis Making. 2022; 42(7):923-936.
PMID: 35607982
PMC: 9459357.
DOI: 10.1177/0272989X221100717.
A permutation procedure to detect heterogeneous treatment effects in randomized clinical trials while controlling the type I error rate.
Wolf J, Koopmeiners J, Vock D
Clin Trials. 2022; 19(5):512-521.
PMID: 35531765
PMC: 9529771.
DOI: 10.1177/17407745221095855.
Diagnostic performance of classification trees and hematological functions in hematologic disorders: an application of multidimensional scaling and cluster analysis.
Rahim F, Kazemnejad A, Jahangiri M, Malehi A, Gohari K
BMC Med Inform Decis Mak. 2021; 21(1):313.
PMID: 34758828
PMC: 8579574.
DOI: 10.1186/s12911-021-01678-5.
A parsimonious personalized dose-finding model via dimension reduction.
Zhou W, Zhu R, Zeng D
Biometrika. 2021; 108(3):643-659.
PMID: 34658383
PMC: 8514170.
DOI: 10.1093/biomet/asaa087.
Heterogeneity of Treatment Effects Among Patients With Type 2 Diabetes and Elevated Body Mass Index in a Study Comparing Group Medical Visits Focused on Weight Management and Medication Intensification.
Kobe E, Crowley M, Jeffreys A, Yancy Jr W, Zervakis J, Edelman D
Med Care. 2021; 59(11):1031-1038.
PMID: 34510104
PMC: 8516740.
DOI: 10.1097/MLR.0000000000001642.
Addressing patient heterogeneity in disease predictive model development.
Gao X, Shen W, Ning J, Feng Z, Hu J
Biometrics. 2021; 78(3):1045-1055.
PMID: 34184256
PMC: 8751174.
DOI: 10.1111/biom.13514.
Developing a predictive signature for two trial endpoints using the cross-validated risk scores method.
Cherlin S, Wason J
Biostatistics. 2021; 24(2):327-344.
PMID: 34165151
PMC: 10102911.
DOI: 10.1093/biostatistics/kxaa055.